MORRIS PLAINS, N.J., Oct. 8, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that it will host a live webcast of its R&D day on Friday, October 15, 2010 from 12:00 p.m. – 2:00 p.m. Eastern Time.
